Vertex Announces Medsafe Consent For TRIKAFTA®To Treat Children With Cystic Fibrosis Ages ...
Vertex Pharmaceuticals today announced that the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has granted consent for the expanded use of TRIKAFTA® ...
Cystic Fibrosis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action ...
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
人民网 on MSN4 小时
暴饮暴食后的“沉默杀手”：急性胰腺炎的三大诱因
暴饮暴食后的“沉默杀手”：急性胰腺炎的三大诱因广西中医药大学第一附属医院仙葫院区刘慧莲急性胰腺炎是胰腺组织因胰酶异常激活而发生的自身消化性炎症，具有起病急、进展快、致死率高的特点。